Targeting the canonical Wnt/β-catenin pathway in hematological malignancies

Cancer Science
E AshiharaT Maekawa

Abstract

The canonical Wnt/β-catenin pathway plays an important role in different developmental processes through the regulation of stem cell functions. In the activation of the canonical Wnt/β-catenin pathway, β-catenin protein is imported into the nucleus and activates transcription of target genes including cyclin D1 and c-myc. Aberrant activation of the Wnt/β-catenin pathway contributes to carcinogenesis and malignant behaviors, and Wnt signaling is essential for the maintenance of cancer stem cells. The canonical Wnt/β-catenin pathway has been investigated extensively as a target in cancer treatment and several specific inhibitors of this signaling pathway have been identified through high-throughput screening. In this review, the significance of the canonical Wnt/β-catenin pathway in hematological carcinogenesis and screening methods for specific inhibitors are discussed.

References

Apr 16, 1998·Acta Dermato-venereologica·T YamamotoK Nishioka
Nov 25, 2000·British Journal of Haematology·F M Abu-DuhierJ T Reilly
Mar 27, 2001·European Journal of Immunology·F J StaalH Clevers
Oct 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Vivienne I RebelDavid M Livingston
Mar 12, 2003·Oncogene·Ya-Wei QiangStuart Rudikoff
Jan 30, 2004·Cancer Cell·Maina LepourceletRamesh A Shivdasani
Feb 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·Desheng LuDennis A Carson
Mar 17, 2004·Molecular and Cellular Biology·Carsten Müller-TidowHubert Serve
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Katayoon H EmamiMichael Kahn
Sep 17, 2004·Nature Reviews. Genetics·Randall T MoonAjamete Kaykas
Jul 1, 2005·Nature·Franziska MichorMartin A Nowak
Dec 7, 2006·Blood·José Román-GómezFelipe Prosper
Mar 22, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kalindi ParmarJulian D Down
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kumar SukhdeoDaniel R Carrasco
Jan 29, 2008·Recent Patents on Anti-cancer Drug Discovery·Shinya Kimura
Dec 11, 2008·European Journal of Haematology·Katharina Salome MinkeKarl-Anton Kreuzer
Dec 17, 2008·Hematology·Catriona H Jamieson
Jan 9, 2009·Cell Stem Cell·Sachin Malhotra, Paul W Kincade
Apr 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eishi AshiharaTaira Maekawa
Sep 18, 2009·Nature·Shih-Min A HuangFeng Cong
Apr 3, 2010·Neoplasia : an International Journal for Oncology Research·Rajesh Kumar GandhirajanKarl-Anton Kreuzer
Dec 16, 2010·The Journal of Clinical Investigation·Amie S CorbinBrian J Druker

❮ Previous
Next ❯

Citations

Jan 25, 2017·Biochemical and Biophysical Research Communications·Natsuki ImayoshiEishi Ashihara
Jun 18, 2016·Integrative Biology : Quantitative Biosciences From Nano to Macro·Jennifer L WilsonDouglas A Lauffenburger
Jul 12, 2017·Leukemia & Lymphoma·Vito Michele GarrisiAttilio Guarini
Feb 23, 2019·Journal of the National Cancer Institute·Motonari NomuraJason T Yustein
Mar 1, 2020·Journal of Applied Toxicology : JAT·Peter C W LuLouise M Winn
Apr 1, 2020·International Journal of Molecular Sciences·Luisa TomaselloClaudio Sorio
Feb 9, 2018·Oncotarget·Liting YangZhaoyang Zeng
Feb 17, 2017·Clinical Epigenetics·Mark E IssaMuriel Cuendet
Sep 20, 2018·Nature Reviews. Cancer·Nikki K LytleTannishtha Reya
Aug 6, 2020·Cells·Marina Mastelaro de RezendeReinoud Gosens
Sep 28, 2020·Journal of Cancer Research and Clinical Oncology·Andrés Cardona-Echeverry, Jeanette Prada-Arismendy
Apr 26, 2017·Oncology Reports·Dong Min KimIl-Chul Kim
Jan 20, 2017·Experimental and Therapeutic Medicine·Likun YanRuiting Liu
Jan 11, 2020·Frontiers in Immunology·Elena Martin-OrozcoMaria Ayala-San Nicolas
Jun 5, 2020·Journal of Experimental & Clinical Cancer Research : CR·Kenly WuputraKazunari K Yokoyama
Feb 13, 2018·Oncotarget·Chao GaoWei Zhang
Aug 26, 2017·Molecular Biology Reports·Ceyda ÇalışkanOgun Sercan
Apr 17, 2020·Journal of Hematology & Oncology·Victor PallarèsRamon Mangues
Sep 9, 2020·Journal of Receptor and Signal Transduction Research·Xiao-Ying JiangLan Xi
Jun 14, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julie J G KephartCorinne M Linardic
Sep 18, 2020·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Bingling DaiYanmin Zhang
Nov 15, 2020·Pathology·Kenon ChuaVictor Kwan Min Lee
Nov 20, 2020·Stem Cell Research & Therapy·Fiorella RossiKarl-Henrik Grinnemo
Jun 2, 2021·Bioorganic & Medicinal Chemistry Letters·Takahiro MatsumotoTetsushi Watanabe

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
nuclear translocation
acetylation
transcriptional profiling

Clinical Trials Mentioned

NCT01302405
NCT01606579

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

© 2021 Meta ULC. All rights reserved